Q1 2025 Holdings
Filed 2025-05-15 | 37 holdings | $560.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $180.5M | 5,612,896 | 32.2% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $91.9M | 11,448,081 | 16.4% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $90.1M | 5,674,916 | 16.1% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $20.1M | 1,717,127 | 3.6% |
| Alumis Inc(ALMS) | COM | 022307102 | $20.1M | 3,266,498 | 3.6% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $19.0M | 679,486 | 3.4% |
| Septerna Inc(SEPN) | COM | 81734D104 | $18.2M | 3,149,128 | 3.3% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $18.0M | 4,415,689 | 3.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $13.5M | 526,390 | 2.4% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $12.7M | 2,067,146 | 2.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $8.9M | 135,276 | 1.6% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $7.9M | 666,667 | 1.4% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $7.6M | 967,527 | 1.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.3M | 138,118 | 1.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $6.9M | 3,768,035 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $6.7M | 6,130,268 | 1.2% |
| Acelyrin Inc | COM | 00445A100 | $6.2M | 2,523,022 | 1.1% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $4.1M | 588,816 | 0.7% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $3.6M | 206,784 | 0.6% |
| Onkure Therapeutics Inc(OKUR) | COM CL A | 68277Q105 | $3.5M | 824,155 | 0.6% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.8M | 241,400 | 0.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $2.7M | 425,000 | 0.5% |
| Sutro Biopharma Inc | COM | 869367102 | $1.4M | 2,196,814 | 0.3% |
| Inozyme Pharma Inc | COM | 45790W108 | $1.4M | 1,562,500 | 0.3% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $875.0K | 291,666 | 0.2% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $863.1K | 630,000 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $806.4K | 405,228 | 0.1% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $745.2K | 2,442,352 | 0.1% |
| Hillevax Inc | COM | 43157M102 | $579.5K | 399,637 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $558.5K | 202,348 | 0.1% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $419.7K | 1,049,153 | 0.1% |
| Curis Inc(CRIS) | COM | 231269309 | $390.5K | 185,943 | 0.1% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $175.6K | 1,390,130 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $64.5K | 78,131 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $42.7K | 133,333 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $39.2K | 172,089 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $3.0K | 99,999 | 0.0% |